Bank Of America Corp Castle Biosciences Inc Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Castle Biosciences Inc stock. As of the latest transaction made, Bank Of America Corp holds 79,612 shares of CSTL stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,612

Previous 151,165 47.33%

Holding current value

$2.22 Million

Previous $3.35 Million 48.24%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $1.35 Million - $1.78 Million	-71,553 Reduced 47.33%	79,612 $1.73 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $227,321 - $318,451	12,587 Added 9.08%	151,165 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $1.15 Million - $2.11 Million	93,937 Added 210.43%	138,578 $2.99 Million
Q2 2023 Aug 14, 2023	SELL	$11.66 - $26.0 $145,994 - $325,546	-12,521 Reduced 21.9%	44,641 $612,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $159,751 - $233,760	8,205 Added 16.76%	57,162 $1.3 Million
Q4 2022 Feb 10, 2023	SELL	$18.08 - $30.0 $1.38 Million - $2.28 Million	-76,117 Reduced 60.86%	48,957 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $1.78 Million - $2.72 Million	79,149 Added 172.34%	125,074 $3.26 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $142,640 - $410,000	8,915 Added 24.09%	45,925 $1.01 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $59,407 - $84,141	-1,791 Reduced 4.62%	37,010 $1.66 Million
Q4 2021 Feb 08, 2022	BUY	$39.06 - $67.58 $696,322 - $1.2 Million	17,827 Added 85.0%	38,801 $1.66 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $103,964 - $134,170	-1,729 Reduced 7.62%	20,974 $1.39 Million
Q2 2021 Sep 13, 2021	BUY	$50.07 - $76.78 $1.14 Million - $1.74 Million	22,703 New	22,703 $1.66 Million

Others Institutions Holding CSTL

# of Institutions

171

Shares Held

25.5M

Call Options Held

511K

Put Options Held

130K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $733M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Castle Biosciences Inc Transaction History